Key Capital HAP-V+ Immune Supplement Reported Effective Against COVID-19, and Colds and Flu
90% Reduction in COVID-19 Virus Infectivity Reported Through Independent University Research Study NEW YORK, NY / ACCESSWIRE / April 26,...
News
Avinger to Announce First Quarter 2021 Results on May 6, 2021
REDWOOD CITY, CA / ACCESSWIRE / April 26, 2021 / Avinger, Inc. (NASDAQ:AVGR), commercial-stage medical device company marketing the first...
Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Treating and Curing Covid-19 Infection Utilizing a Laser
JACKSON CENTER, PA / ACCESSWIRE / April 26, 2021 / Halberd Corporation (OTC PINK:HALB) filed an International Patent Cooperation Treaty...
CLS Holdings USA, Inc. Hits the Holiday Hard, Achieves Record 4/20 Sales
LAS VEGAS, NV / ACCESSWIRE / April 26, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a...
MannKind Reduces Legacy Debt by Approximately $49.5 Million and Restructures Remaining Obligations, including Extended Maturity, Lower Interest Rates and Increased Third Tranche
Paid Off Mann Group Non-Convertible Note of $35.1 Million in Principal plus $4.4 Million in Accrued InterestPrepaid $10.0 Million Owed...
INmune Bio, Inc. Announces Participation in Fireside Chat at the B Riley Neurosciences Conference
LA JOLLA, Calif, April 26, 2021 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage...
Repeat: Core One Labs Vocan Biotechnologies Enters into Collaborative Research Agreement with UBC
VANCOUVER, British Columbia, April 26, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN:...
Turning Point Therapeutics to Host First Quarter 2021 Conference Call
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation...
One World Pharma Announces First Sale of Cuttings in Colombia
LAS VEGAS, NV, April 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire ‒ One World Pharma Inc. (OTC: OWPC), (“OWP” or...
Teladoc Health Names Technology Leader Claus Jensen as Chief Innovation Officer
PURCHASE, NY, April 26, 2021 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care,...
Allied Corp. Announces Clearance From the Colombian Authorities to Export Cannabis Products To Second International Market
KELOWNA, British Columbia, April 26, 2021 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical...
Intuitive Appoints Dr. Monica P. Reed to its Board of Directors
SUNNYVALE, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and...
Better Choice Announces Appointment of Former Blue Buffalo Founding Shareholder, Gil Fronzaglia, to the Board of Directors
NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) -- Better Choice Company (OTCQX: BTTR) (“Better Choice”), an animal health and wellness...
Decentralized Trials & Research Alliance (DTRA) Reaches Milestone of 100 Member Organizations
Growth of Global Industry Alliance Advances Mission to Increase Access to Clinical Trials and Research SAN DIEGO, April 26, 2021...
Cassava Sciences Invited by the NIH to Participate in Sachs 4th Annual Neuroscience Innovation Forum
AUSTIN, Texas, April 26, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s...
Vertex and CRISPR Therapeutics Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to CTX001™ for Transfusion-Dependent Beta Thalassemia
BOSTON and CAMBRIDGE, Mass. and ZUG, Switzerland, April 26, 2021 (GLOBE NEWSWIRE) -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR...
Antares Pharma Appoints Dr. Peter Richardson as Executive Vice President, Research and Development and Chief Medical Officer
EWING, N.J., April 26, 2021 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today...
PetMed Express d/b/a 1-800-PetMeds to Announce Its Fiscal Year End Financial Results on May 3, 2021
DELRAY BEACH, Fla., April 26, 2021 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for...
Advaxis Announces Receipt of Second Milestone Payment Under ADXS-HER2 Licensing Agreement with OS Therapies
Non-dilutive capital to support advancement of ADXS-HOT neoantigen programPRINCETON, N.J., April 26, 2021 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ: ADXS), a...
Algernon Pharmaceuticals Files End of Phase 2 Meeting Request with U.S. FDA for its COVID-19 Trial of Ifenprodil
VANCOUVER, British Columbia, April 26, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or...